Main Therapeutic Uses

Fitostimoline is a dermatological treatment utilized to promote the healing of various skin and tissue conditions. Its primary function is to support the natural repair processes of the body, making it applicable for several types of skin lesions and integrity issues.

Wound Healing and Tissue Repair

The medication is most commonly used for the management of tissue repair disorders. This includes:

• Skin Ulcers: Treatment of chronic wounds such as venous ulcers, pressure sores (decubitus ulcers), and diabetic foot ulcers.
• Burns: Management of first and second-degree burns, helping to restore the skin barrier.
• Surgical Wounds: Application to post-operative sites to facilitate the closing of incisions and reduce healing time.
• Abrasions and Lacerations: Treatment of minor skin injuries, scrapes, and cuts.

Specialized Applications

Beyond general dermatology, certain formulations are used for specific physiological areas:

• Vaginal Health: Specific preparations address alterations in the vaginal mucosa, such as dystrophy or lesions resulting from inflammation or clinical procedures.
• Proctological Care: Use in the repair of anal fissures or tissue damage in the perianal area.

Benefits of Treatment

Fitostimoline provides several physiological benefits that contribute to the restoration of healthy tissue.

Stimulation of Cellular Activity

The active components work by stimulating the activity of fibroblasts, which are cells essential for the production of collagen and connective tissue. This acceleration of cellular metabolism helps the body rebuild the damaged extracellular matrix more efficiently.

Support of the Re-epithelialization Process

The treatment facilitates re-epithelialization, the process by which new epithelial cells migrate across the surface of a wound. This helps in forming a new protective layer of skin, reducing the risk of complications associated with open wounds.

Restoration of the Skin Barrier

By promoting faster healing, Fitostimoline helps restore the skin's natural barrier function. This is critical for maintaining hydration within the tissues and providing a defense against external environmental factors.

Who Can and Cannot Use Fitostimoline?

The official eligibility profile for Fitostimoline (aqueous extract of Triticum vulgare) strictly defines populations based on age, physiological status, and underlying health conditions, as documented in regulatory guidelines.

Contraindications and Restrictions

Category	Regulatory Status
Absolute Contraindication	Patients with known hypersensitivity or allergy to the active substance (Rigenase) or any excipient.
Age Group	Adults (18+ years) are eligible. Children and adolescents (under 18) are generally not recommended for use.
Pregnancy/Lactation	Not Recommended for use in pregnant or breastfeeding women.
Wound Severity	Not Eligible for treating third-degree burns or lesions exceeding 10% of the body surface area.
Comorbidities	Restricted in patients with systemic issues, including immunodeficiency states, neoplastic diseases, or uncontrolled metabolic diseases (e.g., severe diabetes mellitus).

Official Eligibility Summary

Regulatory documents establish the primary eligibility for the adult population. Use in the pediatric population is not established. The product is formally restricted by the presence of certain systemic diseases and the severity of the wound, ensuring it is used only for the intended superficial tissue repair.

The official regulatory profile for Fitostimoline is defined by the absence of documented systemic interactions, a status that is consistent with its topical route of administration and pharmacological properties. All information regarding interactions is based strictly on governmental regulatory sources, such as the Summary of Product Characteristics (SmPC).

---

Absence of Documented Systemic Interactions

The active substance, Aqueous extract of Triticum vulgare (Rigenase), is classified as a topical pharmaceutical preparation. Official regulatory documents from national health authorities state explicitly that interactions or incompatibilities are not known with other medicinal products.

This regulatory designation is supported by official pharmacokinetic findings, which confirm that following topical application, no clinically relevant systemic absorption of the active component has been detected. As a result, the product’s regulatory profile does not list warnings related to systemic pharmacokinetic interactions, such as effects on Cytochrome P450 enzymes or drug transporters (e.g., P-gp), that would alter the plasma concentration of co-administered medicines.

---

Interaction-Related Restrictions

Due to the absence of systemic exposure and known systemic interactions, there are no specific, regulatory-mandated restrictions on the co-administration of Fitostimoline with systemic medications.

• Contraindicated Combinations: None are documented in official regulatory labeling.
• Pharmacodynamic Interactions: No additive, synergistic, or antagonistic effects with systemically absorbed medicines are specified.
• Timing or Separation Requirements: No mandatory time separation requirements for co-administering the drug with other products are listed in official regulatory labels.
• Interactions with Consumption: No interactions with food, alcohol, or herbal products are documented.

How Fitostimoline Works: A Mechanistic Overview

Fitostimoline's pharmacodynamic action involves the engagement and modulation of core biological processes associated with cellular signaling and tissue homeostasis. Its mechanism is categorized across three distinct domains.

Regulation of Local Cytokine and Inflammatory Mediator Signaling

This mechanistic domain focuses on influencing signaling pathways that govern localized cellular defense responses. Fitostimoline initiates the modulation of early molecular steps, specifically regulating the synthesis and release kinetics of cytokines and other inflammatory mediators at the site of action. The modification of mediator signaling cascades leads to a decreased magnitude of inflammatory signaling, altering the systemic physiological feedback.

Influence on Cell Proliferation and Vascular Signaling Pathways

Fitostimoline engages mechanisms that directly influence the mitogenic cascade within responsive cells. This activity modifies signaling sequences that modulate the activation and migration of various cell types, including fibroblasts and endothelial cells. The resultant shift in pathway kinetics is associated with increased cellular mitotic activity and the upregulation of signaling transcripts for neovascularization.

Modulation of Extracellular Matrix Biosynthesis and Organization

This final domain involves the drug's effect on the structural and regulatory components surrounding cells. Fitostimoline influences the biological systems and processes associated with the synthesis, deposition, and organization of collagen and other components of the extracellular matrix (ECM). The resulting biochemical action alters the expression profile of matrix metalloproteinases and structural protein components, influencing the physical organization of the ECM.

How Fitostimoline is Used: Official Administration Guidelines

Fitostimoline, an herbal medicinal product containing an aqueous extract of Triticum vulgare, is administered exclusively via topical or intravaginal routes. Its usage is structured by the specific dosage form—such as cream, gauze, ovules, or solution—as defined in regulatory prescribing information.

---

Dosing and Frequency Patterns

The standard approach involves applying a sufficient quantity of the product to the affected area. Frequency depends strictly on the formulation:

Form Type	Administration Route	Typical Frequency
Cream, Hydrogel	Topical (Cutaneous)	At least twice daily
Gauze Impregnated	Topical (Cutaneous)	Once or twice daily
Ovules, Vaginal Cream/Solution	Intravaginal (Mucosal)	Once or twice daily

The treatment course is maintained until the area shows complete re-epithelialization or healing, a duration determined by the clinical scenario.

---

Procedural and Contextual Instructions

Proper use requires specific preparatory and handling steps. For topical applications, the target lesion must be previously cleansed and/or disinfected before the application of the cream or gauze. When using the impregnated gauze, the dressing must be maintained to ensure it remains humid, soft, and pliable.

For intravaginal use, ovules must be introduced deeply, and irrigation with the vaginal solution should be performed in a supine position. Furthermore, specific instructions confirm the medicine’s use is appropriate during pregnancy and lactation. The administration process mandates that each vaginal applicator provided is used for a single application only.

Research evidence / Overview of studies for Fitostimoline

The research base for Fitostimoline, which contains an aqueous extract of Triticum vulgare (Rigenase), has primarily examined its use as a supportive measure in various skin and mucosal conditions. The available studies help show what has been observed so far regarding the product's application in different types of injuries.

---

Evidence for Use in Acute Superficial Wounds and Abrasions

Research has explored the use of the preparation in short-term Randomized Controlled Trials (RCTs) and other comparative trials involving adult populations with acute, non-complex skin injuries. These studies monitored outcomes such as the measurement of the time required for complete re-epithelialization and wound size reduction. Findings describe data show patterns related to the rate of epithelial recovery observed during the short-term follow-up period.

What remains uncertain is the long-term status of the tissue following repair, as follow-up durations were limited, typically only up to four weeks. Sample sizes were modest in some of the published literature, and the evidence derived from settings with varying symptom burdens was collected in studies using open-label designs, which can limit certainty.

---

Evidence for Use in Chronic and Ulcerative-Dystrophic Skin Damage

The product was evaluated in adult patients with chronic conditions, such as pressure sores or certain grades of diabetic foot ulcers. Studies examined outcomes related to physical discomfort and the measurement of changes in the ulcer size, with observation periods often extending over several months. Findings indicate that some studies using the combination product (Fitostimoline Plus) reported changes related to patient-reported symptoms and local skin signs.

However, the evidence quality varies, and the overall level of certainty remains low. Since several trials used a combination product, the specific role of the Triticum vulgare extract can appear uncertain. Furthermore, data are still emerging regarding the prevention of recurrence or the long-term status of the healed tissue.

---

What Is Still Uncertain About the Research Base

The current evidence landscape highlights several areas where certainty remains low or research is ongoing. The main limitations include that sample sizes were modest in many trials, which can limit the generalizability of findings. Comparative evidence is lacking for some applications when compared against an inactive control (placebo). Research does not determine whether an individual will respond similarly; study results reflect the specific conditions under which they were conducted.

Key Studies & References

1. Treatment of Vaginal Atrophy with the Aqueous Extract of Triticum Vulgare: Comparison Between Different Pharmaceutical Forms
2. Fitostimoline® Septagel Product Information (Polyhexanide and Rigenase®)

Common questions about Fitostimoline (FAQ)

---

Q: Is Fitostimoline available over-the-counter, or does it require a prescription?

The market classification for Fitostimoline varies depending on the country and local regulatory guidelines. In some jurisdictions, the product is classified in a way that allows for non-prescription (over-the-counter) availability. Patients are generally advised to check the product's classification and purchasing requirements in their specific region to confirm availability.

---

Q: What is the difference between the cream, gel, and gauze formulations of Fitostimoline?

All formulations contain the same active ingredient, Triticum vulgare extract, but they are tailored for different application needs. For example, impregnated gauzes are typically utilized for chronic wounds, ulcers, or deeper sores that require maintenance dressing. Conversely, the cream or hydrogel forms may be suggested for easier application on superficial abrasions or widespread skin areas. The choice of formulation is generally based on the characteristics and location of the lesion.

---

Q: Why do people commonly use Fitostimoline for burns and scalds?

Official product information describes its use for promoting skin regeneration and healing in first and second-degree burns and scalds. The regulatory profile clearly restricts its use and excludes third-degree burns from its intended use. Its regulatory role is defined as supporting the natural process of tissue restoration.

---

Q: How quickly are effects of Fitostimoline expected to be seen, according to research studies?

Studies that investigate the product's effect on acute injuries, such as second-degree burns, typically monitor the time required for complete re-epithelialization. These clinical observations often indicate that the healing process may be completed within approximately two to four weeks. It is noted that these findings reflect general research observations, and individual outcomes may vary based on the specific condition.

---

Q: Are there any specific warnings about using Fitostimoline for deep or infected wounds?

The main formulations of Fitostimoline are generally designed for superficial lesions, and its use is officially restricted for severe injuries, such as third-degree burns or wounds exceeding 10% of the body surface area. Some combination products (like Fitostimoline Plus) include an antiseptic component to help manage the wound microenvironment.

---

Q: What does the official product information say about using Fitostimoline during pregnancy?

Official regulatory documents contain conflicting statements regarding use during pregnancy. While some information implies that use is appropriate, other parts of the official documentation state that it is not recommended for pregnant women. Due to this regulatory inconsistency, patients with potential usage questions are advised to seek guidance from a qualified healthcare professional.

---

Q: Is Fitostimoline listed as safe to use while breastfeeding?

Regulatory documents present conflicting information regarding the use of the product while breastfeeding. Some official guidance suggests it may be appropriate, yet other documentation states that it is not recommended. In cases of uncertainty, seeking guidance from a qualified healthcare professional is suggested.

---

Q: Can Fitostimoline be applied simultaneously with other topical medications?

Official documents state that interactions or incompatibilities are not known with other systemically absorbed medicinal products. However, clinical studies often excluded patients who were also receiving treatment with local corticosteroids or other specific topical antiseptics. Seeking clarification from a health professional is suggested when considering the co-administration of multiple topical treatments.

---

Q: What steps are officially recommended if a user experiences a reaction to Fitostimoline?

If a patient experiences a local adverse reaction, such as burning, pain, redness, or itching, the general guidance provided by regulatory bodies is to discontinue the application of the product. If the symptoms do not resolve or if the reaction is severe, official pharmacovigilance guidance references the need for seeking prompt medical attention from a healthcare professional.

---

Storage and Disposal of Fitostimoline

The storage of Fitostimoline (aqueous extract of Triticum vulgare) is strictly defined by regulatory requirements to ensure product stability.

---

Official Storage Requirements

• Temperature Restrictions: The product must not be stored above 30 C and must not be frozen. Maintaining this temperature range is crucial for the formulation's integrity.
• Packaging and Stability: The stated expiration date is only valid if the medicine is kept in its intact and correctly stored original package.
• Child Safety: Fitostimoline must be kept out of the reach and sight of children.

---

Disposal Instructions

• Waste Handling: Unused or expired product and any waste material must not be disposed of in the environment or with ordinary household waste.
• Regulatory Compliance: Disposal must be carried out according to local regulatory requirements, typically by returning it to a pharmacy or designated collection point.